Klaus Früh seminar November 6

Klaus Früh, Ph.D.
Oregon Health Sciences University

“New Vaccine Strategies Using Cytomegalovirus”

Tuesday, November 6
11:30 a.m.
143 Jones Building

Host: Bryan Cullen

Dr. Klaus Früh has spent a considerable part of his career defining how human CMV blocks various antiviral pathogens in order to establish long-term, chronic infections. More recently, he has used this knowledge to develop human CMV as a platform for the induction of long-term immune responses that can effectively protect against other pathogenic viruses. This work will be the focus of this seminar.